Filtros de búsqueda

Lista de obras de Gerardo Musuraca

A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma

artículo científico publicado en 2008

A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.

artículo científico publicado en 2008

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia

artículo científico publicado en 2011

Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report.

artículo científico publicado en 2015

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies.

artículo científico publicado en 2018

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

artículo científico publicado en 2016

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.

artículo científico publicado en 2006

Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas

artículo científico publicado en 2005

Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients

artículo científico publicado en 2003

Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).

artículo científico publicado en 2008

Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma

artículo científico publicado en 2004

High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience

scientific article published on 01 May 2003

High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience

artículo científico publicado en 2004

Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.

artículo científico publicado en 2007

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia

artículo científico publicado en 2015

Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays

artículo científico publicado en 2005

Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients

artículo científico publicado en 2010

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience

artículo científico publicado en 2021

Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.

artículo científico publicado en 2004

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia

artículo científico publicado en 2015

Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma

artículo científico publicado en 2007

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients

artículo científico publicado en 2004

Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma.

artículo científico publicado en 2007

Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma

artículo científico publicado en 2008

Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G)

artículo científico publicado en 2010

Rituximab plus Bendamustine as front line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin's lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.

artículo científico publicado en 2018

Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma

artículo científico publicado en 2009

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly

artículo científico publicado en 2007

Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma

artículo científico publicado en 2005